IP Library Granted Patent US 11,376,334
Granted Patent B2
US 11,376,334 · App. 16/936,265 · Granted Jul 5, 2022

Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate

Inventors: Stepan Chuprakov (Emeryville, CA); Romas Alvydas Kudirka (El Cerrito, CA); Jesse M. McFarland (Berkeley, CA); Albert W. Garafalo (South San Francisco, CA); David Rabuka (Kensington, CA)
Assignee: R.P. Scherer Technologies, LLC
A61K47/6803A61K47/545C07D498/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,376,334
App. No.
16/936,265
Granted
Jul 5, 2022
Kind
B2
Abstract

The present disclosure provides conjugate structures and hydrazinyl-substituted heteroaryl compounds used to produce these conjugates. The disclosure also encompasses methods of production of such conjugates and compounds, as well as methods of using the same.

Claims (576)

1. A method of delivering a conjugate to a subject, the method comprising:

administering to the subject an effective amount of a conjugate comprising at least one modified amino acid residue of formula (I):

wherein:

R 1 and R 2 are each independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

one of R 3 and R 4 is a polypeptide and the other is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

R 5 and R 6 are each independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or R 5 and R 6 are cyclically linked to form a 5 or 6-membered heterocyclyl;

Z 1 is selected from CR 7 , N, O and S;

Z 2 is C or N;

R 7 is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

L is a linker; and

W is a drug or a detectable label.

2. The method of claim 1 , wherein Z 1 and Z 2 are each N.

3. The method of claim 1 , wherein Z 1 is CR 7 and Z 2 is N.

4. The method of claim 1 , wherein Z 1 is O and Z 2 is C.

5. The method of claim 1 , wherein R 3 is the polypeptide.

6. The method of claim 1 , wherein R 4 is the polypeptide.

7. The method of claim 1 , wherein R 5 and R 6 are each independently selected from alkyl and substituted alkyl.

8. The method of claim 1 , wherein R 7 is hydrogen.

9. The method of claim 1 , wherein:

the linker is of the formula -(T 1 -V 1 ) a -(T 2 -V 2 ) b -(T 3 -V 3 ) c -(T 4 -V 4 ) d -(T 5 -V 5 ) e —, wherein a, b, c, d and e are each independently 0 or 1, where the sum of a, b, c, d and e is 1 to 5;

T 1 , T 2 , T 3 , T 4 and T 5 are each independently selected from (C 1 -C 12 )alkyl, substituted (C 1 -C 12 )alkyl, (EDA) w , (PEG) n , (AA) p , —(CR 13 0H) h -, 4-amino-piperidinyl (4AP), para-aminobenzyl (PAB), para-amino-benzyloxy (PABO), meta-amino-benzyloxy (MABO), para-amino-benzyloxycarbonyl (PABC), meta-amino-benzyloxycarbonyl (MABC), an acetal group, a disulfide, a hydrazine, a carbohydrate, a beta-lactam, an ester, (AA) p -MABO, (AA) p -MABC, (AA) p -PABO, (AA) p -PABC, MABO-(AA) p , MABC-(AA) p , PABO-(AA) p , PABC-(AA) p , (AA) p -MABO-(AA) p , (AA) p -MABC-(AA) p , (AA) p -PABO-(AA) p , and (AA) p -PABC-(AA) p ;

V 1 , V 2 , V 3 , V 4 and V 5 are each independently selected from the group consisting of a covalent bond, —CO—, —NR 11 —, —CONR 11 —, —NR 11 CO—, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO 2 —, —SO 2 NR 11 —, —NR 11 SO 2 — and —P(O)OH—;

each R 11 and R 13 is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

w is an integer from 1 to 20;

n is an integer from 1 to 30;

p is an integer from 1 to 20; and

h is an integer from 1 to 12.

10. The method of claim 9 , wherein:

EDA is an ethylene diamine having the structure:

wherein q is an integer from 1 to 6, r is 0 or 1, and each R 12 is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or wherein two adjacent R 12 groups are cyclically linked to form a piperazinyl ring;

PEG is a polyethylene glycol or a substituted polyethylene glycol;

AA is an amino acid residue; and

4AP is

wherein each R 14 is independently selected from hydrogen, alkyl, substituted alkyl, polyethylene glycol, substituted polyethylene glycol, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

11. The method of claim 10 , wherein each R 11 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

12. The method of claim 10 , wherein each R 12 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or wherein two adjacent R 12 groups are cyclically linked to form a piperazinyl ring.

13. The method of claim 10 , wherein each R 13 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, and substituted aryl.

14. The method of claim 10 , wherein each R 14 is independently selected from hydrogen, alkyl, substituted alkyl, polyethylene glycol, substituted polyethylene glycol, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

15. The method of claim 10 , wherein T 1 , T 2 , T 3 , T 4 and T 5 and V 1 , V 2 , T 3 , V 4 and V 5 are selected from the following table:

T 1

V 1

T 2

V 2

T 3

V 3

T 4

V 4

T 5

V 5

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(C 1 -C 12 )alkyl

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(EDA) w

(C 1 -C 12 )alkyl

—CO—

(EDA) w

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—SO 2 —

(AA) p

(C 1 -C 12 )alkyl

—CO—

(CR 13 OH) h

—CO—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(PEG) n

—CO—

(C 1 -C 12 )alkyl

—CONR 11 —

substituted

—NR 11 —

(PEG) n

—CO—

(C 1 -C 12 )alkyl

(C 1 -C 12 )alkyl

—SO2—

(C 1 -C 12 )alkyl

—CO—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

(CR 13 OH) h

—CONR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—P(O)OH—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

—CO—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

—CO—

(C 1 -C 12 )alkyl

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(PEG) n

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

MABC

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

MABC

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p —

—NR 11 —

(C 1 -

—CO—

PABC

C 12 )

alkyl

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

PABC

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

PABO

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p—

PABC-

(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

PABC-

(AA) p

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

PABO

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

PABO

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

MABO

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

PABC

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

MABC

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

PABC

(AA) p

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

MABO

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

PABO

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

PABC

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

MABC

(AA) p

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

PABC

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

PABC

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

PABC-

(AA) p

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—.

16. The method of claim 10 , wherein the linker is selected from one of the following structures:

wherein:

each f is independently 0 or an integer from 1 to 12;

each n is independently 0 or an integer from 1 to 30;

each y is independently 0 or an integer from 1 to 20;

each h is independently 0 or an integer from 1 to 12;

each p is independently 0 or an integer from 1 to 20;

each R is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; and

each R′ is independently selected from hydrogen, a sidechain group of an amino acid, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

Assignments (2)
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2020
From: CHUPRAKOV, STEPAN; KUDIRKA, ROMAS ALVYDAS; MCFARLAND, JESSE M.; GAROFALO, ALBERT W.; RABUKA, DAVID
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 053815/0385 →